Clinilabs
Clinilabs Drug Development Corporation is the only global, full-service contract research organization (CRO) focused exclusively on central nervous system ("CNS") drug development. With deep expertise in CNS, we are committed to the development of medicines that treat a range of psychiatric, neurological and substance use disorders, as well as rare and ultra-rare CNS diseases. Clinilabs partners with pharmaceutical and biotechnology companies to deliver a complete, first-in-human to Phase 3 spectrum of high quality, timely, and cost-effective clinical drug development services, with the shared goal of speeding new CNS medicines to market. We are process-driven yet structured to be nimble, providing personalized service that meets the needs of customers and projects of all sizes. Clinilabs has conducted more than 675 CNS clinical trials in our 21-year history and played a pivotal role in the approval of 19 new therapies across 10 CNS indications to help transform the lives of patients worldwide.
About Clinilabs
Founded
2001Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$4MCategory
Industry
ResearchLocation
City
New York CityState
New YorkCountry
United StatesTech Stack (116)
Marketing
Devops And Development
Widgets
WP Rocket
ThemeFusion
GTranslate.io
Gtranslate for Wordpress
Slack
Yoast Plugins
Slider Revolution
The Events Calendar
ThemePunch
UberMenu
Google Translate Widget
Wordpress Plugins
Google Font API
Sitelinks Search Box
Google Tag Manager
COVID-19
Simply Schedule Appointments
US Privacy User Signal Mechanism
Site Kit
CrUX Dataset